Sales of Olainfarm in September Increase by 17% Olaine,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
28
Sales of Olainfarm in September Increase by 17%

Olaine, 2017-10-16 15:15 CEST (GLOBE NEWSWIRE) --

September 2017, consolidated sales Sales, thsnd. EUR Changes to September 2016 Share in total sales
Russia 3 447 69% 36%
Latvia 2 728 13% 28%
Ukraine 1 021 54% 11%
Belarus 674 24% 7%
Kazakhstan 375 -18% 4%
The Netherlands 146 -73% 2%
Uzbekistan 144 388% 1%
Lithuania 141 37% 1%
Germany 129 159% 1%
Albania 111 232% 1%
Other 712 -46% 7%
Total 9 628 17% 100%

Sales of pharmacies of SIA Latvijas Aptieka during September 2017 were 1.94 million euros, which represents an increase by 21% compared to September 2016.  Sixty-nine pharmacies were operating during this period.  Sales of SIA Silvanols in September 2017 were 0.55 million euros, which represents a reduction by 13% compared to the same period of last year.  During September 2017, SIA Silvanols sold its products in four European countries and with the mediation of AS Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of SIA Tonus Elast in September reached 0.74 million euros, which represents an increase by 40% compared to September 2016.  Its products were sold to 16 countries in three continents.

According to preliminary consolidated results, sales of AS Olainfarm group in nine months of 2017 reached 85.61 million euros, which represents an increase by 9% compared to nine months of 2016.  The biggest sales increase during this period was achieved in Germany, where sales grew by 200%, but sales to The Netherlands increased by 133%.  The biggest sales reduction was experienced in Ukraine where sales shrunk by 39%.  Major sales markets of AS Olainfarm group in nine months of 2017 were Russia, Latvia, Belarus and Ukraine.

9 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 9 months of 2016 Share in total sales
Russia 28 382 23% 33%
Latvia 21 611 13% 25%
Belarus 7 696 22% 9%
Ukraine 7 412 -39% 9%
The Netherlands 3 814 133% 4%
Kazakhstan 2 640 30% 3%
Uzbekistan 1 397 -22% 2%
Germany 1 305 200% 2%
Lithuania 1 129 18% 1%
Turkmenistan 1 023 -4% 1%
Other 9 200 -8% 11%
Total 85 609 9% 100%

Sales of pharmacies of SIA Latvijas Aptieka in nine months of 2017 reached 15.7 million euros, which represents an increase by 13% compared to nine months of 2016.  Sales of SIA Silvanols in nine months reached 3.89 million euros, which represents an increase by 6% compared to 9 months of 2016.  Products of SIA Silvanols were sold to twelve European countries and with the help of AS Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of SIA Tonus Elast in nine months reached 6.17 million euros and its products were sold to 37 countries in four continents.

According to preliminary unconsolidated results, sales of AS Olainfarm in September 2017 were 7.55 million euros, which represents an increase by 17% compared to September 2016.  The biggest sales increase was achieved in Uzbekistan, where sales grew by 388%.  Sales to Albania increased by 232%, sales to Germany increased by 161%, sales to Lithuania increases by 81%, sales to Ukraine increased by 63% and sales to Russia increased by 59%.  Biggest sales reduction was experienced in the Netherlands, where sales shrunk by 73% and in Kazakhstan, where sales shrunk by 69%.  Biggest sales markets during September 2017 were Russia, Latvia, Ukraine and Belarus.  During September 2017, products of As Olainfarm were sold to 32 countries in Asia and Europe.

September 2017, unconsolidated sales Sales, thsnd. EUR Changes to September 2016 Share in total sales
Russia 3 255 59% 43%
Latvia 1 334 9% 18%
Ukraine 1 021 63% 14%
Belarus 674 24% 9%
The Netherlands 146 -73% 2%
Uzbekistan 144 388% 2%
Lithuania 135 81% 2%
Germany 129 161% 2%
Kazakhstan 121 -69% 2%
Albania 111 232% 1%
Other 482 -46% 6%
Total 7 552 17% 100%

According to preliminary unconsolidated results of As Olainfarm for nine months of 2017, sales of the company during this period reached 68.42 million euros, which represents an increase by 4% compared to nine months of 2016. The biggest sales increase was achieved in Germany, where sales increased by 202% and in The Netherlands, where sales grew by 133%.  Biggest sales reduction was experienced in Ukraine, where sales shrunk by 40%. Major sales markets of AS Olainfarm during this period were Russia, Latvia, Belarus and Ukraine.  In total, during nine months of 2017, products of Olainfarm were sold to 48 countries in five continents.

9 months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to nine months of 2016 Share in total sales
Russia 25 946 15% 38%
Latvia 10 602 7% 15%
Belarus 7 602 21% 11%
Ukraine 7 228 -40% 11%
The Netherlands 3 814 133% 6%
Kazakhstan 1 774 3% 3%
Uzbekistan 1 397 -22% 2%
Germany 1 292 202% 2%
Turkmenistan 1 023 -4% 1%
Italy 954 36% 1%
Other 6 789 -14% 10%
Total 68 421 4% 100%

General meeting of shareholders of AS Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros.  According to these preliminary sales numbers, in nine months of 2017 the company has met 71% of annual target for unconsolidated sales and 67% of annual target for consolidated sales.

 JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

         Information prepared by:                    Salvis Lapins          JSC Olainfarm          Member of the Management Board          Rupnicu iela 5, Olaine, Latvia, LV 2114          Phone: +371 6 7013 717          Fax: +371 6 7013 777          E-mail: Salvis.Lapins@olainfarm.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 1

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
UNISORB Expands Reach with BILZ Acquisition

Updated Category News Views 0

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 4

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Backroads Sets 2027 Egypt Tour with Active Adventures

Updated Category News Views 1

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
Evotec and Plectonic Join Forces on Tumor Immunotherapy

Updated Category News Views 4

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading

Top 5 Most Recently Viewed Articles

EUROAPI's Strategic Sale of Haverhill Site to Particle Dynamics

Updated Category News Views 209

EUROAPI Strategically Divests Haverhill Site EUROAPI has undertaken a significant step in optimizing its industrial footprint by announcing the sale of its Haverhill manufacturing site to Particle Dynamics, a prominent name in particle processing and delivery technologies. This transaction reinforces EUROAPI's commitment to its FOCUS-27 transformation plan aimed at...

Continue Reading
Safe and Green Development Corporation Achieves Financial Milestone

Updated Category News Views 150

Safe and Green Development Corporation Achieves Financial Stability Miami — Safe and Green Development Corporation (NASDAQ: SGD), a prominent player in the real estate and technology development sector, recently made headlines with an important announcement: the complete satisfaction and retirement of all outstanding convertible debt obligations. This is more than just...

Continue Reading
Ethan Allen Prepares for Fiscal 2025 Second Quarter Earnings

Updated Category News Views 174

Ethan Allen's Upcoming Earnings Release Ethan Allen Interiors Inc. is gearing up for the release of its financial results for the fiscal 2025 second quarter, which concluded on December 31, 2024. This announcement reflects the company’s commitment to transparency and engagement with its stakeholders. The release is anticipated to occur after market hours on a Wednesday,...

Continue Reading
MY DR NOW Expands Convenient Family Care in Chandler Area

Updated Category News Views 103

MY DR NOW Opens New Family Clinic to Serve Busy Families MY DR NOW, known for its dedication to family health, has recently opened a family medicine clinic designed with the busy lifestyles of modern families in mind. This new clinic in Chandler is a game-changer for families trying to fit healthcare into their hectic schedules. Strategic Location for Easy Access...

Continue Reading
Nykredit Realkredit A/S Updates on Prepayments Insights

Updated Category News Views 150

Understanding Nykredit Realkredit A/S Prepayment Updates Nykredit Realkredit A/S is dedicated to keeping its investors informed on key financial metrics. Today, we explore the latest updates on prepayments data, specifically pertaining to CK93. Key Highlights from the Prepayment Data The latest prepayment data for CK93, as mandated by the Danish Capital Markets Act,...

Continue Reading